#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


1-1	0-7	Altered	_
1-2	8-19	Small-World	_
1-3	20-28	Networks	_
1-4	29-31	in	_
1-5	32-45	First-Episode	http://maven.renci.org/NeuroBridge/neurobridge#FirstEpisodePsychosis
1-6	46-59	Schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#FirstEpisodePsychosis
1-7	60-68	Patients	http://maven.renci.org/NeuroBridge/neurobridge#FirstEpisodePsychosis
1-8	69-75	during	_
1-9	76-80	Cool	http://maven.renci.org/NeuroBridge/neurobridge#BehaviorRatingInventoryOfExecutiveFunction
1-10	81-90	Executive	http://maven.renci.org/NeuroBridge/neurobridge#BehaviorRatingInventoryOfExecutiveFunction
1-11	91-99	Function	http://maven.renci.org/NeuroBridge/neurobridge#BehaviorRatingInventoryOfExecutiveFunction
1-12	100-104	Task	http://maven.renci.org/NeuroBridge/neurobridge#BehaviorRatingInventoryOfExecutiveFunction
1-13	105-107	At	_
1-14	108-115	present	_
1-15	116-117	,	_
1-16	118-124	little	_
1-17	125-127	is	_
1-18	128-133	known	_
1-19	134-139	about	_
1-20	140-145	brain	_
1-21	146-156	functional	_
1-22	157-169	connectivity	_
1-23	170-173	and	_
1-24	174-177	its	_
1-25	178-189	small-world	_
1-26	190-199	topologic	_
1-27	200-210	properties	_
1-28	211-213	in	_
1-29	214-227	first-episode	http://maven.renci.org/NeuroBridge/neurobridge#AcuteSchizophrenicEpisode
1-30	228-241	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#AcuteSchizophrenicEpisode
1-31	242-243	(	http://maven.renci.org/NeuroBridge/neurobridge#AcuteSchizophrenicEpisode
1-32	244-246	SZ	http://maven.renci.org/NeuroBridge/neurobridge#AcuteSchizophrenicEpisode
1-33	247-248	)	http://maven.renci.org/NeuroBridge/neurobridge#AcuteSchizophrenicEpisode
1-34	249-257	patients	http://maven.renci.org/NeuroBridge/neurobridge#AcuteSchizophrenicEpisode
1-35	258-264	during	_
1-36	265-269	cool	_
1-37	270-279	executive	_
1-38	280-288	function	http://maven.renci.org/NeuroBridge/neurobridge#DevelopmentalDisorderofMotorFunction
1-39	289-293	task	http://maven.renci.org/NeuroBridge/neurobridge#DevelopmentalDisorderofMotorFunction
1-40	294-295	.	_

2-1	296-298	In	_
2-2	299-303	this	_
2-3	304-309	paper	_
2-4	310-311	,	_
2-5	312-315	the	_
2-6	316-321	Trail	http://maven.renci.org/NeuroBridge/neurobridge#II
2-7	322-328	Making	http://maven.renci.org/NeuroBridge/neurobridge#II
2-8	329-335	Test-B	http://maven.renci.org/NeuroBridge/neurobridge#II
2-9	336-337	(	http://maven.renci.org/NeuroBridge/neurobridge#II
2-10	338-343	TMT-B	http://maven.renci.org/NeuroBridge/neurobridge#II
2-11	344-345	)	http://maven.renci.org/NeuroBridge/neurobridge#II
2-12	346-350	task	http://maven.renci.org/NeuroBridge/neurobridge#II
2-13	351-354	was	_
2-14	355-359	used	_
2-15	360-362	to	_
2-16	363-371	evaluate	_
2-17	372-375	the	_
2-18	376-380	cool	_
2-19	381-390	executive	_
2-20	391-399	function	_
2-21	400-402	of	_
2-22	403-416	first-episode	http://maven.renci.org/NeuroBridge/neurobridge#FirstEpisodePsychosis
2-23	417-419	SZ	http://maven.renci.org/NeuroBridge/neurobridge#FirstEpisodePsychosis
2-24	420-428	patients	http://maven.renci.org/NeuroBridge/neurobridge#FirstEpisodePsychosis
2-25	429-432	and	_
2-26	433-455	electroencephalography	_
2-27	456-457	(	http://maven.renci.org/NeuroBridge/neurobridge#Thing
2-28	458-461	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Thing
2-29	462-463	)	http://maven.renci.org/NeuroBridge/neurobridge#Thing
2-30	464-468	data	_
2-31	469-473	were	_
2-32	474-482	recorded	_
2-33	483-487	from	_
2-34	488-490	14	_
2-35	491-504	first-episode	http://maven.renci.org/NeuroBridge/neurobridge#FirstEpisodePsychosis
2-36	505-507	SZ	http://maven.renci.org/NeuroBridge/neurobridge#FirstEpisodePsychosis
2-37	508-516	patients	http://maven.renci.org/NeuroBridge/neurobridge#FirstEpisodePsychosis
2-38	517-520	and	_
2-39	521-523	14	_
2-40	524-531	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
2-41	532-540	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
2-42	541-547	during	_
2-43	548-552	this	_
2-44	553-557	cool	http://maven.renci.org/NeuroBridge/neurobridge#BehaviorRatingInventoryOfExecutiveFunction
2-45	558-567	executive	http://maven.renci.org/NeuroBridge/neurobridge#BehaviorRatingInventoryOfExecutiveFunction
2-46	568-576	function	http://maven.renci.org/NeuroBridge/neurobridge#BehaviorRatingInventoryOfExecutiveFunction
2-47	577-581	task	http://maven.renci.org/NeuroBridge/neurobridge#BehaviorRatingInventoryOfExecutiveFunction
2-48	582-583	.	_

3-1	584-589	Brain	_
3-2	590-600	functional	_
3-3	601-613	connectivity	_
3-4	614-621	between	_
3-5	622-625	all	_
3-6	626-631	pairs	_
3-7	632-634	of	_
3-8	635-638	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
3-9	639-647	channels	_
3-10	648-651	was	_
3-11	652-663	constructed	_
3-12	664-669	based	_
3-13	670-672	on	_
3-14	673-679	mutual	_
3-15	680-691	information	_
3-16	692-693	(	_
3-17	694-696	MI	_
3-18	697-698	)	_
3-19	699-707	analysis	_
3-20	708-709	.	_

4-1	710-713	The	_
4-2	714-725	constructed	_
4-3	726-731	brain	_
4-4	732-742	functional	_
4-5	743-751	networks	_
4-6	752-756	were	_
4-7	757-765	filtered	_
4-8	766-768	by	_
4-9	769-774	three	_
4-10	775-787	thresholding	_
4-11	788-795	schemes	_
4-12	796-797	:	_
4-13	798-806	absolute	_
4-14	807-816	threshold	_
4-15	817-818	,	_
4-16	819-823	mean	_
4-17	824-830	degree	_
4-18	831-832	,	_
4-19	833-836	and	_
4-20	837-838	a	_
4-21	839-844	novel	_
4-22	845-856	data-driven	_
4-23	857-863	scheme	_
4-24	864-869	based	_
4-25	870-872	on	_
4-26	873-883	orthogonal	_
4-27	884-891	minimal	_
4-28	892-900	spanning	_
4-29	901-906	trees	_
4-30	907-908	(	_
4-31	909-913	OMST	_
4-32	914-915	)	_
4-33	916-917	,	_
4-34	918-921	and	_
4-35	922-927	graph	_
4-36	928-934	theory	_
4-37	935-938	was	_
4-38	939-943	then	_
4-39	944-948	used	_
4-40	949-951	to	_
4-41	952-957	study	_
4-42	958-961	the	_
4-43	962-975	topographical	_
4-44	976-991	characteristics	_
4-45	992-994	of	_
4-46	995-998	the	_
4-47	999-1007	filtered	_
4-48	1008-1013	brain	_
4-49	1014-1020	graphs	_
4-50	1021-1022	.	_

5-1	1023-1030	Results	_
5-2	1031-1040	indicated	_
5-3	1041-1045	that	_
5-4	1046-1049	the	_
5-5	1050-1055	graph	_
5-6	1056-1067	theoretical	_
5-7	1068-1076	measures	_
5-8	1077-1079	of	_
5-9	1080-1083	the	_
5-10	1084-1089	theta	_
5-11	1090-1094	band	_
5-12	1095-1101	showed	_
5-13	1102-1109	obvious	_
5-14	1110-1120	difference	_
5-15	1121-1128	between	_
5-16	1129-1131	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
5-17	1132-1140	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
5-18	1141-1144	and	_
5-19	1145-1152	healthy	_
5-20	1153-1161	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
5-21	1162-1163	.	_

6-1	1164-1166	In	_
6-2	1167-1170	the	_
6-3	1171-1176	theta	_
6-4	1177-1181	band	_
6-5	1182-1183	,	_
6-6	1184-1187	the	_
6-7	1188-1202	characteristic	_
6-8	1203-1207	path	_
6-9	1208-1214	length	_
6-10	1215-1218	was	_
6-11	1219-1232	significantly	_
6-12	1233-1239	longer	_
6-13	1240-1243	and	_
6-14	1244-1247	the	_
6-15	1248-1255	cluster	_
6-16	1256-1267	coefficient	_
6-17	1268-1271	was	_
6-18	1272-1285	significantly	_
6-19	1286-1293	smaller	_
6-20	1294-1296	in	_
6-21	1297-1300	the	_
6-22	1301-1303	SZ	_
6-23	1304-1312	patients	_
6-24	1313-1316	for	_
6-25	1317-1318	a	_
6-26	1319-1323	wide	_
6-27	1324-1329	range	_
6-28	1330-1332	of	_
6-29	1333-1341	absolute	_
6-30	1342-1351	threshold	_
6-31	1352-1354	T.	_
6-32	1355-1362	However	_
6-33	1363-1364	,	_
6-34	1365-1368	the	_
6-35	1369-1376	cluster	_
6-36	1377-1388	coefficient	_
6-37	1389-1395	showed	_
6-38	1396-1398	no	_
6-39	1399-1410	significant	_
6-40	1411-1418	changes	_
6-41	1419-1420	,	_
6-42	1421-1424	and	_
6-43	1425-1428	the	_
6-44	1429-1443	characteristic	_
6-45	1444-1448	path	_
6-46	1449-1455	length	_
6-47	1456-1459	was	_
6-48	1460-1465	still	_
6-49	1466-1479	significantly	_
6-50	1480-1486	longer	_
6-51	1487-1489	in	_
6-52	1490-1492	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Thing
6-53	1493-1501	patients	_
6-54	1502-1506	when	_
6-55	1507-1517	calculated	_
6-56	1518-1520	as	_
6-57	1521-1522	a	_
6-58	1523-1531	function	_
6-59	1532-1534	of	_
6-60	1535-1539	mean	_
6-61	1540-1546	degree	_
6-62	1547-1549	K.	_
6-63	1550-1563	Interestingly	_
6-64	1564-1565	,	_
6-65	1566-1568	we	_
6-66	1569-1573	also	_
6-67	1574-1579	found	_
6-68	1580-1584	that	_
6-69	1585-1589	only	_
6-70	1590-1593	the	_
6-71	1594-1608	characteristic	_
6-72	1609-1613	path	_
6-73	1614-1620	length	_
6-74	1621-1624	was	_
6-75	1625-1638	significantly	_
6-76	1639-1645	longer	_
6-77	1646-1648	in	_
6-78	1649-1651	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Thing
6-79	1652-1660	patients	_
6-80	1661-1669	compared	_
6-81	1670-1674	with	_
6-82	1675-1682	healthy	_
6-83	1683-1691	controls	_
6-84	1692-1697	after	_
6-85	1698-1703	using	_
6-86	1704-1707	the	_
6-87	1708-1712	OMST	_
6-88	1713-1719	scheme	_
6-89	1720-1721	.	_

7-1	1722-1729	Pearson	_
7-2	1730-1741	correlation	_
7-3	1742-1750	analysis	_
7-4	1751-1757	showed	_
7-5	1758-1762	that	_
7-6	1763-1766	the	_
7-7	1767-1781	characteristic	_
7-8	1782-1786	path	_
7-9	1787-1793	length	_
7-10	1794-1797	was	_
7-11	1798-1808	positively	_
7-12	1809-1819	correlated	_
7-13	1820-1824	with	_
7-14	1825-1834	executive	_
7-15	1835-1839	time	_
7-16	1840-1842	of	_
7-17	1843-1848	TMT-B	_
7-18	1849-1852	for	_
7-19	1853-1856	the	_
7-20	1857-1865	combined	_
7-21	1866-1868	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Thing
7-22	1869-1877	patients	_
7-23	1878-1881	and	_
7-24	1882-1889	healthy	_
7-25	1890-1898	controls	_
7-26	1899-1900	(	_
7-27	1901-1902	r	_
7-28	1903-1904	=	_
7-29	1905-1910	0.507	_
7-30	1911-1912	,	_
7-31	1913-1914	P	_
7-32	1915-1916	=	_
7-33	1917-1922	0.006	_
7-34	1923-1924	)	_
7-35	1925-1926	,	_
7-36	1927-1930	but	_
7-37	1931-1934	not	_
7-38	1935-1938	for	_
7-39	1939-1941	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Thing
7-40	1942-1950	patients	_
7-41	1951-1956	alone	_
7-42	1957-1958	(	_
7-43	1959-1960	r	_
7-44	1961-1962	=	_
7-45	1963-1968	0.072	_
7-46	1969-1970	,	_
7-47	1971-1972	P	_
7-48	1973-1974	=	_
7-49	1975-1980	0.612	_
7-50	1981-1982	)	_
7-51	1983-1984	.	_

8-1	1985-1988	The	_
8-2	1989-1994	above	_
8-3	1995-2002	results	_
8-4	2003-2012	suggested	_
8-5	2013-2014	a	_
8-6	2015-2019	less	_
8-7	2020-2027	optimal	_
8-8	2028-2040	organization	_
8-9	2041-2043	of	_
8-10	2044-2047	the	_
8-11	2048-2053	brain	_
8-12	2054-2061	network	_
8-13	2062-2065	and	_
8-14	2066-2071	could	_
8-15	2072-2074	be	_
8-16	2075-2081	useful	_
8-17	2082-2085	for	_
8-18	2086-2099	understanding	_
8-19	2100-2103	the	_
8-20	2104-2120	pathophysiologic	_
8-21	2121-2131	mechanisms	_
8-22	2132-2142	underlying	_
8-23	2143-2147	cool	_
8-24	2148-2157	executive	_
8-25	2158-2169	dysfunction	_
8-26	2170-2172	in	_
8-27	2173-2186	first-episode	http://maven.renci.org/NeuroBridge/neurobridge#FirstEpisodePsychosis
8-28	2187-2189	SZ	http://maven.renci.org/NeuroBridge/neurobridge#FirstEpisodePsychosis
8-29	2190-2198	patients	http://maven.renci.org/NeuroBridge/neurobridge#FirstEpisodePsychosis
8-30	2199-2200	.	_

9-1	2201-2202	2	_
9-2	2203-2204	.	_

10-1	2205-2214	Materials	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
10-2	2215-2218	and	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
10-3	2219-2226	Methods	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
10-4	2227-2230	2.1	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
10-5	2231-2232	.	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod

11-1	2233-2241	Subjects	_
11-2	2242-2244	14	_
11-3	2245-2258	first-episode	http://maven.renci.org/NeuroBridge/neurobridge#FirstEpisodePsychosis
11-4	2259-2261	SZ	http://maven.renci.org/NeuroBridge/neurobridge#FirstEpisodePsychosis
11-5	2262-2270	patients	http://maven.renci.org/NeuroBridge/neurobridge#FirstEpisodePsychosis
11-6	2271-2272	(	_
11-7	2273-2274	9	_
11-8	2275-2279	male	_
11-9	2280-2283	and	_
11-10	2284-2285	5	_
11-11	2286-2292	female	_
11-12	2293-2294	)	_
11-13	2295-2299	were	_
11-14	2300-2309	recruited	_
11-15	2310-2314	from	_
11-16	2315-2318	the	_
11-17	2319-2324	Henan	_
11-18	2325-2336	Psychiatric	_
11-19	2337-2345	Hospital	_
11-20	2346-2348	of	_
11-21	2349-2354	China	_
11-22	2355-2364	according	_
11-23	2365-2367	to	_
11-24	2368-2371	the	_
11-25	2372-2382	Structured	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
11-26	2383-2391	Clinical	_
11-27	2392-2401	Interview	_
11-28	2402-2405	for	_
11-29	2406-2412	DSM-IV	_
11-30	2413-2414	,	_
11-31	2415-2418	and	_
11-32	2419-2422	any	_
11-33	2423-2431	patients	_
11-34	2432-2436	with	_
11-35	2437-2438	a	_
11-36	2439-2446	history	_
11-37	2447-2449	of	_
11-38	2450-2460	medication	_
11-39	2461-2470	treatment	_
11-40	2471-2472	,	_
11-41	2473-2477	drug	_
11-42	2478-2494	abuse/dependence	_
11-43	2495-2496	,	_
11-44	2497-2514	electroconvulsive	_
11-45	2515-2522	therapy	_
11-46	2523-2524	,	_
11-47	2525-2527	or	_
11-48	2528-2533	other	_
11-49	2534-2545	psychiatric	_
11-50	2546-2549	and	_
11-51	2550-2562	neurological	_
11-52	2563-2571	diseases	_
11-53	2572-2576	were	_
11-54	2577-2585	excluded	_
11-55	2586-2587	.	_

12-1	2588-2591	The	_
12-2	2592-2596	mean	_
12-3	2597-2600	age	_
12-4	2601-2603	of	_
12-5	2604-2607	the	_
12-6	2608-2610	14	_
12-7	2611-2613	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
12-8	2614-2622	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
12-9	2623-2626	was	_
12-10	2627-2632	28.21	_
12-11	2633-2634	±	_
12-12	2635-2639	6.94	_
12-13	2640-2645	years	_
12-14	2646-2647	,	_
12-15	2648-2651	the	_
12-16	2652-2656	mean	_
12-17	2657-2665	duration	_
12-18	2666-2668	of	_
12-19	2669-2676	illness	_
12-20	2677-2680	was	_
12-21	2681-2686	18.26	_
12-22	2687-2688	±	_
12-23	2689-2693	7.03	_
12-24	2694-2700	months	_
12-25	2701-2702	,	_
12-26	2703-2706	and	_
12-27	2707-2710	all	_
12-28	2711-2719	patients	_
12-29	2720-2723	are	_
12-30	2724-2736	right-handed	_
12-31	2737-2738	.	_

13-1	2739-2742	For	_
13-2	2743-2750	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
13-3	2751-2759	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
13-4	2760-2761	,	_
13-5	2762-2763	a	_
13-6	2764-2769	group	_
13-7	2770-2772	of	_
13-8	2773-2775	14	_
13-9	2776-2784	subjects	_
13-10	2785-2792	matched	_
13-11	2793-2796	for	_
13-12	2797-2800	sex	_
13-13	2801-2802	,	_
13-14	2803-2806	age	_
13-15	2807-2808	,	_
13-16	2809-2812	and	_
13-17	2813-2821	dominant	_
13-18	2822-2826	side	_
13-19	2827-2830	was	_
13-20	2831-2840	recruited	_
13-21	2841-2842	(	_
13-22	2843-2844	9	_
13-23	2845-2849	male	_
13-24	2850-2853	and	_
13-25	2854-2855	5	_
13-26	2856-2862	female	_
13-27	2863-2864	;	_
13-28	2865-2869	mean	_
13-29	2870-2873	age	_
13-30	2874-2875	:	_
13-31	2876-2881	25.13	_
13-32	2882-2883	±	_
13-33	2884-2888	3.75	_
13-34	2889-2890	;	_
13-35	2891-2894	all	_
13-36	2895-2907	right-handed	_
13-37	2908-2909	)	_
13-38	2910-2911	,	_
13-39	2912-2915	and	_
13-40	2916-2919	any	_
13-41	2920-2927	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
13-42	2928-2936	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
13-43	2937-2941	with	_
13-44	2942-2943	a	_
13-45	2944-2948	past	_
13-46	2949-2951	or	_
13-47	2952-2959	current	_
13-48	2960-2971	psychiatric	_
13-49	2972-2979	illness	_
13-50	2980-2981	,	_
13-51	2982-2986	drug	_
13-52	2987-2997	dependence	_
13-53	2998-2999	,	_
13-54	3000-3012	neurological	_
13-55	3013-3022	disorders	_
13-56	3023-3024	,	_
13-57	3025-3027	or	_
13-58	3028-3034	severe	_
13-59	3035-3042	somatic	_
13-60	3043-3051	diseases	_
13-61	3052-3056	were	_
13-62	3057-3065	excluded	_
13-63	3066-3067	.	_

14-1	3068-3071	The	_
14-2	3072-3077	study	_
14-3	3078-3081	was	_
14-4	3082-3090	approved	_
14-5	3091-3093	by	_
14-6	3094-3097	the	_
14-7	3098-3104	ethics	_
14-8	3105-3114	committee	_
14-9	3115-3117	of	_
14-10	3118-3123	Henan	_
14-11	3124-3135	Psychiatric	_
14-12	3136-3144	Hospital	_
14-13	3145-3147	of	_
14-14	3148-3153	China	_
14-15	3154-3155	,	_
14-16	3156-3159	and	_
14-17	3160-3162	an	_
14-18	3163-3171	informed	_
14-19	3172-3179	consent	_
14-20	3180-3184	form	_
14-21	3185-3188	was	_
14-22	3189-3195	signed	_
14-23	3196-3198	by	_
14-24	3199-3202	all	_
14-25	3203-3215	participants	_
14-26	3216-3222	before	_
14-27	3223-3226	the	_
14-28	3227-3237	experiment	_
14-29	3238-3239	.	_

15-1	3240-3243	2.2	_
15-2	3244-3245	.	_

16-1	3246-3249	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
16-2	3250-3260	Recordings	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
16-3	3261-3264	and	_
16-4	3265-3267	MI	_
16-5	3268-3279	Computation	_
16-6	3280-3283	The	_
16-7	3284-3287	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
16-8	3288-3292	data	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
16-9	3293-3297	were	_
16-10	3298-3306	recorded	_
16-11	3307-3311	from	_
16-12	3312-3315	all	_
16-13	3316-3328	participants	_
16-14	3329-3333	when	_
16-15	3334-3338	they	_
16-16	3339-3343	were	_
16-17	3344-3354	performing	_
16-18	3355-3356	a	_
16-19	3357-3361	cool	http://maven.renci.org/NeuroBridge/neurobridge#BehaviorRatingInventoryOfExecutiveFunction
16-20	3362-3371	executive	http://maven.renci.org/NeuroBridge/neurobridge#BehaviorRatingInventoryOfExecutiveFunction
16-21	3372-3380	function	http://maven.renci.org/NeuroBridge/neurobridge#BehaviorRatingInventoryOfExecutiveFunction
16-22	3381-3385	task	http://maven.renci.org/NeuroBridge/neurobridge#BehaviorRatingInventoryOfExecutiveFunction
16-23	3386-3387	,	_
16-24	3388-3392	that	_
16-25	3393-3395	is	_
16-26	3396-3397	,	_
16-27	3398-3401	the	_
16-28	3402-3407	TMT-B	http://maven.renci.org/NeuroBridge/neurobridge#VisfatinMeasurementData
16-29	3408-3412	task	http://maven.renci.org/NeuroBridge/neurobridge#VisfatinMeasurementData
16-30	3413-3414	.	_

17-1	3415-3417	As	_
17-2	3418-3421	for	_
17-3	3422-3425	the	_
17-4	3426-3431	TMT-B	_
17-5	3432-3436	task	_
17-6	3437-3441	that	_
17-7	3442-3451	evaluates	_
17-8	3452-3457	quick	_
17-9	3458-3464	visual	_
17-10	3465-3471	search	_
17-11	3472-3473	,	_
17-12	3474-3480	visual	_
17-13	3481-3486	space	_
17-14	3487-3494	sorting	_
17-15	3495-3496	,	_
17-16	3497-3500	and	_
17-17	3501-3510	cognitive	_
17-18	3511-3514	set	_
17-19	3515-3523	transfer	_
17-20	3524-3533	functions	_
17-21	3534-3535	,	_
17-22	3536-3539	the	_
17-23	3540-3552	participants	_
17-24	3553-3557	were	_
17-25	3558-3563	asked	_
17-26	3564-3566	to	_
17-27	3567-3574	connect	_
17-28	3575-3582	numbers	_
17-29	3583-3584	(	_
17-30	3585-3589	1–13	_
17-31	3590-3591	)	_
17-32	3592-3595	and	_
17-33	3596-3603	letters	_
17-34	3604-3605	(	_
17-35	3606-3609	A–M	_
17-36	3610-3611	)	_
17-37	3612-3617	using	_
17-38	3618-3619	a	_
17-39	3620-3623	pen	_
17-40	3624-3626	on	_
17-41	3627-3628	a	_
17-42	3629-3634	paper	_
17-43	3635-3644	according	_
17-44	3645-3647	to	_
17-45	3648-3650	an	_
17-46	3651-3662	alternating	_
17-47	3663-3671	sequence	_
17-48	3672-3674	as	_
17-49	3675-3679	fast	_
17-50	3680-3682	as	_
17-51	3683-3691	possible	_
17-52	3692-3693	,	_
17-53	3694-3697	and	_
17-54	3698-3701	the	_
17-55	3702-3705	pen	_
17-56	3706-3709	tip	_
17-57	3710-3713	can	_
17-58	3714-3717	not	_
17-59	3718-3723	leave	_
17-60	3724-3727	the	_
17-61	3728-3733	paper	_
17-62	3734-3740	during	_
17-63	3741-3745	this	_
17-64	3746-3753	process	_
17-65	3754-3755	.	_

18-1	3756-3759	The	_
18-2	3760-3769	execution	_
18-3	3770-3774	time	_
18-4	3775-3777	to	_
18-5	3778-3786	complete	_
18-6	3787-3791	this	_
18-7	3792-3796	task	_
18-8	3797-3800	and	_
18-9	3801-3804	the	_
18-10	3805-3810	error	_
18-11	3811-3817	number	_
18-12	3818-3822	that	_
18-13	3823-3825	is	_
18-14	3826-3829	the	_
18-15	3830-3836	number	_
18-16	3837-3839	of	_
18-17	3840-3851	incorrectly	_
18-18	3852-3858	linked	_
18-19	3859-3866	numbers	_
18-20	3867-3870	and	_
18-21	3871-3878	letters	_
18-22	3879-3883	were	_
18-23	3884-3888	used	_
18-24	3889-3891	to	_
18-25	3892-3900	evaluate	_
18-26	3901-3904	the	_
18-27	3905-3909	task	_
18-28	3910-3921	performance	_
18-29	3922-3924	of	_
18-30	3925-3928	the	_
18-31	3929-3941	participants	_
18-32	3942-3943	.	_

19-1	3944-3947	The	_
19-2	3948-3951	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
19-3	3952-3956	data	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
19-4	3957-3961	were	_
19-5	3962-3970	recorded	_
19-6	3971-3973	at	_
19-7	3974-3975	a	_
19-8	3976-3984	sampling	_
19-9	3985-3989	rate	_
19-10	3990-3992	of	_
19-11	3993-3997	1000	_
19-12	3998-4000	Hz	_
19-13	4001-4005	from	_
19-14	4006-4008	24	_
19-15	4009-4017	channels	_
19-16	4018-4019	(	_
19-17	4020-4023	FP1	_
19-18	4024-4025	,	_
19-19	4026-4029	FPz	_
19-20	4030-4031	,	_
19-21	4032-4035	FP2	_
19-22	4036-4037	,	_
19-23	4038-4041	AF3	_
19-24	4042-4043	,	_
19-25	4044-4047	AF4	_
19-26	4048-4049	,	_
19-27	4050-4052	F7	_
19-28	4053-4054	,	_
19-29	4055-4057	F5	_
19-30	4058-4059	,	_
19-31	4060-4062	F3	_
19-32	4063-4064	,	_
19-33	4065-4067	F1	_
19-34	4068-4069	,	_
19-35	4070-4072	Fz	_
19-36	4073-4074	,	_
19-37	4075-4077	F2	_
19-38	4078-4079	,	_
19-39	4080-4082	F4	_
19-40	4083-4084	,	_
19-41	4085-4087	F6	_
19-42	4088-4089	,	_
19-43	4090-4092	F8	_
19-44	4093-4094	,	_
19-45	4095-4097	T7	_
19-46	4098-4099	,	_
19-47	4100-4102	C3	_
19-48	4103-4104	,	_
19-49	4105-4107	C4	_
19-50	4108-4109	,	_
19-51	4110-4112	T8	_
19-52	4113-4114	,	_
19-53	4115-4117	P7	_
19-54	4118-4119	,	_
19-55	4120-4122	P3	_
19-56	4123-4124	,	_
19-57	4125-4127	P4	_
19-58	4128-4129	,	_
19-59	4130-4132	P8	_
19-60	4133-4134	,	_
19-61	4135-4137	O1	_
19-62	4138-4139	,	_
19-63	4140-4143	and	_
19-64	4144-4146	O2	_
19-65	4147-4148	)	_
19-66	4149-4153	that	_
19-67	4154-4158	were	_
19-68	4159-4166	mounted	_
19-69	4167-4169	on	_
19-70	4170-4173	the	_
19-71	4174-4179	scalp	_
19-72	4180-4184	with	_
19-73	4185-4186	a	_
19-74	4187-4197	64-channel	_
19-75	4198-4201	EEG	_
19-76	4202-4205	cap	_
19-77	4206-4215	according	_
19-78	4216-4218	to	_
19-79	4219-4222	the	_
19-80	4223-4228	10-20	_
19-81	4229-4237	standard	_
19-82	4238-4244	system	_
19-83	4245-4246	.	_

20-1	4247-4250	And	_
20-2	4251-4254	the	_
20-3	4255-4264	impedance	_
20-4	4265-4267	of	_
20-5	4268-4271	all	_
20-6	4272-4282	electrodes	_
20-7	4283-4286	was	_
20-8	4287-4292	below	_
20-9	4293-4295	10	_
20-10	4296-4298	kΩ	_
20-11	4299-4300	.	_

21-1	4301-4308	Offline	_
21-2	4309-4312	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
21-3	4313-4326	preprocessing	_
21-4	4327-4330	was	_
21-5	4331-4338	carried	_
21-6	4339-4342	out	_
21-7	4343-4345	by	_
21-8	4346-4351	using	_
21-9	4352-4358	Matlab	_
21-10	4359-4364	7.7.0	_
21-11	4365-4371	R2010a	_
21-12	4372-4380	software	_
21-13	4381-4382	(	_
21-14	4383-4392	Mathworks	_
21-15	4393-4397	Inc.	_
21-16	4398-4399	,	_
21-17	4400-4403	USA	_
21-18	4404-4405	)	_
21-19	4406-4414	equipped	_
21-20	4415-4419	with	_
21-21	4420-4423	the	_
21-22	4424-4430	EEGLAB	_
21-23	4431-4438	toolbox	_
21-24	4439-4440	.	_

22-1	4441-4448	Firstly	_
22-2	4449-4450	,	_
22-3	4451-4452	a	_
22-4	4453-4459	0.5–30	_
22-5	4460-4462	Hz	_
22-6	4463-4473	zero-phase	_
22-7	4474-4482	bandpass	_
22-8	4483-4489	filter	_
22-9	4490-4493	was	_
22-10	4494-4501	applied	_
22-11	4502-4503	.	_

23-1	4504-4508	Then	_
23-2	4509-4510	,	_
23-3	4511-4517	ocular	_
23-4	4518-4521	and	_
23-5	4522-4531	prominent	_
23-6	4532-4538	muscle	_
23-7	4539-4548	artifacts	_
23-8	4549-4553	were	_
23-9	4554-4561	removed	_
23-10	4562-4564	by	_
23-11	4565-4570	means	_
23-12	4571-4573	of	_
23-13	4574-4585	independent	_
23-14	4586-4595	component	_
23-15	4596-4604	analysis	_
23-16	4605-4606	(	_
23-17	4607-4610	ICA	_
23-18	4611-4612	)	_
23-19	4613-4614	,	_
23-20	4615-4618	and	_
23-21	4619-4622	the	_
23-22	4623-4630	average	_
23-23	4631-4637	number	_
23-24	4638-4640	of	_
23-25	4641-4652	artifactual	_
23-26	4653-4664	independent	_
23-27	4665-4675	components	_
23-28	4676-4679	was	_
23-29	4680-4683	3.1	_
23-30	4684-4685	±	_
23-31	4686-4689	0.8	_
23-32	4690-4691	(	_
23-33	4692-4696	mean	_
23-34	4697-4698	±	_
23-35	4699-4702	std	_
23-36	4703-4704	)	_
23-37	4705-4708	and	_
23-38	4709-4712	3.4	_
23-39	4713-4714	±	_
23-40	4715-4718	0.7	_
23-41	4719-4720	(	_
23-42	4721-4725	mean	_
23-43	4726-4727	±	_
23-44	4728-4731	std	_
23-45	4732-4733	)	_
23-46	4734-4737	for	_
23-47	4738-4745	healthy	_
23-48	4746-4754	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
23-49	4755-4758	and	_
23-50	4759-4761	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Thing
23-51	4762-4770	patients	_
23-52	4771-4772	,	_
23-53	4773-4785	respectively	_
23-54	4786-4787	.	_

24-1	4788-4800	Subsequently	_
24-2	4801-4802	,	_
24-3	4803-4806	the	_
24-4	4807-4810	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
24-5	4811-4815	data	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
24-6	4816-4820	were	_
24-7	4821-4828	divided	_
24-8	4829-4833	into	_
24-9	4834-4843	10-second	_
24-10	4844-4850	epochs	_
24-11	4851-4854	and	_
24-12	4855-4865	recomputed	_
24-13	4866-4873	against	_
24-14	4874-4877	the	_
24-15	4878-4885	average	_
24-16	4886-4895	reference	_
24-17	4896-4897	.	_

25-1	4898-4905	Finally	_
25-2	4906-4907	,	_
25-3	4908-4911	the	_
25-4	4912-4921	following	_
25-5	4922-4923	4	_
25-6	4924-4933	frequency	_
25-7	4934-4939	bands	_
25-8	4940-4944	were	_
25-9	4945-4953	obtained	_
25-10	4954-4959	using	_
25-11	4960-4961	a	_
25-12	4962-4972	zero-phase	_
25-13	4973-4981	bandpass	_
25-14	4982-4988	filter	_
25-15	4989-4990	:	_
25-16	4991-4996	delta	_
25-17	4997-4998	(	_
25-18	4999-5004	0.5–3	_
25-19	5005-5007	Hz	_
25-20	5008-5009	)	_
25-21	5010-5011	,	_
25-22	5012-5017	theta	_
25-23	5018-5019	(	_
25-24	5020-5023	4–7	_
25-25	5024-5026	Hz	_
25-26	5027-5028	)	_
25-27	5029-5030	,	_
25-28	5031-5036	alpha	_
25-29	5037-5038	(	_
25-30	5039-5043	8–13	_
25-31	5044-5046	Hz	_
25-32	5047-5048	)	_
25-33	5049-5050	,	_
25-34	5051-5054	and	_
25-35	5055-5059	beta	_
25-36	5060-5061	(	_
25-37	5062-5067	13–30	_
25-38	5068-5070	Hz	_
25-39	5071-5072	)	_
25-40	5073-5074	.	_

26-1	5075-5077	MI	_
26-2	5078-5080	is	_
26-3	5081-5086	based	_
26-4	5087-5089	on	_
26-5	5090-5101	information	_
26-6	5102-5108	theory	_
26-7	5109-5112	and	_
26-8	5113-5116	can	_
26-9	5117-5119	be	_
26-10	5120-5124	used	_
26-11	5125-5127	to	_
26-12	5128-5135	measure	_
26-13	5136-5139	the	_
26-14	5140-5146	amount	_
26-15	5147-5149	of	_
26-16	5150-5161	information	_
26-17	5162-5166	that	_
26-18	5167-5170	can	_
26-19	5171-5173	be	_
26-20	5174-5182	obtained	_
26-21	5183-5188	about	_
26-22	5189-5192	one	_
26-23	5193-5201	variable	_
26-24	5202-5206	from	_
26-25	5207-5210	the	_
26-26	5211-5222	measurement	_
26-27	5223-5225	of	_
26-28	5226-5233	another	_
26-29	5234-5235	.	_

27-1	5236-5239	The	_
27-2	5240-5244	main	_
27-3	5245-5254	advantage	_
27-4	5255-5257	of	_
27-5	5258-5260	MI	_
27-6	5261-5263	is	_
27-7	5264-5268	that	_
27-8	5269-5271	it	_
27-9	5272-5277	takes	_
27-10	5278-5285	account	_
27-11	5286-5288	of	_
27-12	5289-5293	both	_
27-13	5294-5300	linear	_
27-14	5301-5304	and	_
27-15	5305-5314	nonlinear	_
27-16	5315-5327	dependencies	_
27-17	5328-5329	.	_

28-1	5330-5333	The	_
28-2	5334-5342	detailed	_
28-3	5343-5354	calculation	_
28-4	5355-5361	method	_
28-5	5362-5364	of	_
28-6	5365-5367	MI	_
28-7	5368-5371	was	_
28-8	5372-5381	described	_
28-9	5382-5384	in	_
28-10	5385-5389	some	_
28-11	5390-5400	previously	_
28-12	5401-5410	published	_
28-13	5411-5421	literature	_
28-14	5422-5423	.	_

29-1	5424-5431	Briefly	_
29-2	5432-5433	,	_
29-3	5434-5439	given	_
29-4	5440-5443	two	_
29-5	5444-5450	random	_
29-6	5451-5460	variables	_
29-7	5461-5462	X	_
29-8	5463-5466	and	_
29-9	5467-5468	Y	_
29-10	5469-5470	,	_
29-11	5471-5474	the	_
29-12	5475-5483	pairwise	_
29-13	5484-5486	MI	_
29-14	5487-5489	is	_
29-15	5490-5497	defined	_
29-16	5498-5500	as	_
29-17	5501-5506	where	_
29-18	5507-5509	PX	_
29-19	5510-5511	(	_
29-20	5512-5513	x	_
29-21	5514-5515	)	_
29-22	5516-5518	is	_
29-23	5519-5522	the	_
29-24	5523-5534	probability	_
29-25	5535-5539	that	_
29-26	5540-5541	x	_
29-27	5542-5544	is	_
29-28	5545-5550	drawn	_
29-29	5551-5555	from	_
29-30	5556-5557	X	_
29-31	5558-5561	and	_
29-32	5562-5565	PXY	_
29-33	5566-5567	(	_
29-34	5568-5569	x	_
29-35	5570-5571	,	_
29-36	5572-5573	y	_
29-37	5574-5575	)	_
29-38	5576-5578	is	_
29-39	5579-5582	the	_
29-40	5583-5588	joint	_
29-41	5589-5600	probability	_
29-42	5601-5608	density	_
29-43	5609-5617	function	_
29-44	5618-5621	for	_
29-45	5622-5625	the	_
29-46	5626-5638	measurements	_
29-47	5639-5641	of	_
29-48	5642-5643	X	_
29-49	5644-5647	and	_
29-50	5648-5649	Y	_
29-51	5650-5654	that	_
29-52	5655-5662	produce	_
29-53	5663-5666	the	_
29-54	5667-5673	values	_
29-55	5674-5675	x	_
29-56	5676-5679	and	_
29-57	5680-5682	y.	_
29-58	5683-5685	MI	_
29-59	5686-5688	is	_
29-60	5689-5698	estimated	_
29-61	5699-5703	from	_
29-62	5704-5705	a	_
29-63	5706-5712	finite	_
29-64	5713-5719	number	_
29-65	5720-5722	of	_
29-66	5723-5730	samples	_
29-67	5731-5732	,	_
29-68	5733-5736	and	_
29-69	5737-5740	the	_
29-70	5741-5752	probability	_
29-71	5753-5762	densities	_
29-72	5763-5764	,	_
29-73	5765-5767	PX	_
29-74	5768-5769	(	_
29-75	5770-5771	x	_
29-76	5772-5773	)	_
29-77	5774-5777	and	_
29-78	5778-5781	PXY	_
29-79	5782-5783	(	_
29-80	5784-5785	x	_
29-81	5786-5787	,	_
29-82	5788-5789	y	_
29-83	5790-5791	)	_
29-84	5792-5793	,	_
29-85	5794-5797	are	_
29-86	5798-5810	approximated	_
29-87	5811-5813	by	_
29-88	5814-5823	histogram	_
29-89	5824-5825	(	_
29-90	5826-5831	using	_
29-91	5832-5835	bin	_
29-92	5836-5840	size	_
29-93	5841-5843	of	_
29-94	5844-5847	100	_
29-95	5848-5849	)	_
29-96	5850-5851	.	_

30-1	5852-5855	For	_
30-2	5856-5857	a	_
30-3	5858-5862	fair	_
30-4	5863-5873	comparison	_
30-5	5874-5880	across	_
30-6	5881-5889	subjects	_
30-7	5890-5893	and	_
30-8	5894-5903	frequency	_
30-9	5904-5909	bands	_
30-10	5910-5911	,	_
30-11	5912-5916	here	_
30-12	5917-5919	we	_
30-13	5920-5928	computed	_
30-14	5929-5932	the	_
30-15	5933-5943	normalized	_
30-16	5944-5946	MI	_
30-17	5947-5949	as	_
30-18	5950-5955	where	_
30-19	5956-5957	H	_
30-20	5958-5959	(	_
30-21	5960-5961	X	_
30-22	5962-5963	)	_
30-23	5964-5967	and	_
30-24	5968-5969	H	_
30-25	5970-5971	(	_
30-26	5972-5973	X	_
30-27	5974-5975	)	_
30-28	5976-5979	are	_
30-29	5980-5983	the	_
30-30	5984-5993	entropies	_
30-31	5994-5997	and	_
30-32	5998-5999	H	_
30-33	6000-6001	(	_
30-34	6002-6003	X	_
30-35	6004-6005	)	_
30-36	6006-6008	is	_
30-37	6009-6016	defined	_
30-38	6017-6019	as	_
30-39	6020-6024	∑xPX	_
30-40	6025-6026	(	_
30-41	6027-6028	x	_
30-42	6029-6030	)	_
30-43	6031-6037	log2PX	_
30-44	6038-6039	(	_
30-45	6040-6041	x	_
30-46	6042-6043	)	_
30-47	6044-6045	.	_

31-1	6046-6049	The	_
31-2	6050-6060	normalized	_
31-3	6061-6063	MI	_
31-4	6064-6066	is	_
31-5	6067-6069	in	_
31-6	6070-6073	the	_
31-7	6074-6079	range	_
31-8	6080-6082	of	_
31-9	6083-6084	[	_
31-10	6085-6086	0	_
31-11	6087-6088	,	_
31-12	6089-6090	1	_
31-13	6091-6092	]	_
31-14	6093-6094	.	_

32-1	6095-6099	Here	_
32-2	6100-6101	,	_
32-3	6102-6105	the	_
32-4	6106-6110	data	_
32-5	6111-6114	are	_
32-6	6115-6124	separated	_
32-7	6125-6129	into	_
32-8	6130-6139	10-second	_
32-9	6140-6146	epochs	_
32-10	6147-6150	for	_
32-11	6151-6153	MI	_
32-12	6154-6165	computation	_
32-13	6166-6168	in	_
32-14	6169-6174	order	_
32-15	6175-6177	to	_
32-16	6178-6186	increase	_
32-17	6187-6190	the	_
32-18	6191-6197	sample	_
32-19	6198-6202	size	_
32-20	6203-6205	as	_
32-21	6206-6210	well	_
32-22	6211-6213	as	_
32-23	6214-6216	to	_
32-24	6217-6224	enhance	_
32-25	6225-6228	the	_
32-26	6229-6241	stationarity	_
32-27	6242-6245	and	_
32-28	6246-6257	consistency	_
32-29	6258-6260	of	_
32-30	6261-6264	the	_
32-31	6265-6267	MI	_
32-32	6268-6279	computation	_
32-33	6280-6281	.	_

33-1	6282-6284	MI	_
33-2	6285-6292	between	_
33-3	6293-6296	all	_
33-4	6297-6302	pairs	_
33-5	6303-6305	of	_
33-6	6306-6309	EEG	_
33-7	6310-6318	channels	_
33-8	6319-6322	was	_
33-9	6323-6331	computed	_
33-10	6332-6333	,	_
33-11	6334-6343	resulting	_
33-12	6344-6346	in	_
33-13	6347-6348	a	_
33-14	6349-6351	24	_
33-15	6352-6353	×	_
33-16	6354-6356	24	_
33-17	6357-6363	matrix	_
33-18	6364-6365	(	_
33-19	6366-6368	24	_
33-20	6369-6371	is	_
33-21	6372-6375	the	_
33-22	6376-6382	number	_
33-23	6383-6385	of	_
33-24	6386-6389	EEG	_
33-25	6390-6398	channels	_
33-26	6399-6400	)	_
33-27	6401-6402	.	_

34-1	6403-6406	For	_
34-2	6407-6411	each	_
34-3	6412-6417	epoch	_
34-4	6418-6419	,	_
34-5	6420-6423	the	_
34-6	6424-6426	MI	_
34-7	6427-6433	matrix	_
34-8	6434-6437	was	_
34-9	6438-6446	computed	_
34-10	6447-6448	,	_
34-11	6449-6452	and	_
34-12	6453-6455	an	_
34-13	6456-6463	average	_
34-14	6464-6466	MI	_
34-15	6467-6473	matrix	_
34-16	6474-6477	for	_
34-17	6478-6482	each	_
34-18	6483-6490	subject	_
34-19	6491-6494	was	_
34-20	6495-6503	obtained	_
34-21	6504-6506	by	_
34-22	6507-6516	averaging	_
34-23	6517-6520	the	_
34-24	6521-6523	MI	_
34-25	6524-6532	matrixes	_
34-26	6533-6543	calculated	_
34-27	6544-6548	from	_
34-28	6549-6552	all	_
34-29	6553-6559	epochs	_
34-30	6560-6561	.	_

35-1	6562-6571	According	_
35-2	6572-6574	to	_
35-3	6575-6578	the	_
35-4	6579-6584	above	_
35-5	6585-6592	process	_
35-6	6593-6594	,	_
35-7	6595-6598	the	_
35-8	6599-6601	MI	_
35-9	6602-6610	matrixes	_
35-10	6611-6614	for	_
35-11	6615-6618	the	_
35-12	6619-6634	above-mentioned	_
35-13	6635-6639	four	_
35-14	6640-6649	frequency	_
35-15	6650-6655	bands	_
35-16	6656-6657	(	_
35-17	6658-6663	delta	_
35-18	6664-6665	:	_
35-19	6666-6671	0.5–3	_
35-20	6672-6674	Hz	_
35-21	6675-6676	,	_
35-22	6677-6682	theta	_
35-23	6683-6684	:	_
35-24	6685-6688	4–7	_
35-25	6689-6691	Hz	_
35-26	6692-6693	,	_
35-27	6694-6699	alpha	_
35-28	6700-6701	:	_
35-29	6702-6706	8–13	_
35-30	6707-6709	Hz	_
35-31	6710-6711	,	_
35-32	6712-6715	and	_
35-33	6716-6720	beta	_
35-34	6721-6722	:	_
35-35	6723-6728	13–30	_
35-36	6729-6731	Hz	_
35-37	6732-6733	)	_
35-38	6734-6738	were	_
35-39	6739-6747	computed	_
35-40	6748-6749	.	_

36-1	6750-6753	2.3	_
36-2	6754-6755	.	_

37-1	6756-6761	Graph	_
37-2	6762-6773	Theoretical	_
37-3	6774-6782	Analysis	_
37-4	6783-6785	In	_
37-5	6786-6790	this	_
37-6	6791-6796	paper	_
37-7	6797-6798	,	_
37-8	6799-6802	the	_
37-9	6803-6805	MI	_
37-10	6806-6812	matrix	_
37-11	6813-6816	was	_
37-12	6817-6826	converted	_
37-13	6827-6831	into	_
37-14	6832-6834	an	_
37-15	6835-6845	undirected	_
37-16	6846-6852	binary	_
37-17	6853-6858	graph	_
37-18	6859-6861	by	_
37-19	6862-6870	applying	_
37-20	6871-6876	three	_
37-21	6877-6884	network	_
37-22	6885-6894	filtering	_
37-23	6895-6902	schemes	_
37-24	6903-6904	:	_
37-25	6905-6913	absolute	_
37-26	6914-6923	threshold	_
37-27	6924-6925	T	_
37-28	6926-6927	,	_
37-29	6928-6932	mean	_
37-30	6933-6939	degree	_
37-31	6940-6941	K	_
37-32	6942-6943	,	_
37-33	6944-6947	and	_
37-34	6948-6952	OMST	_
37-35	6953-6959	method	_
37-36	6960-6961	.	_

38-1	6962-6969	Because	_
38-2	6970-6975	there	_
38-3	6976-6978	is	_
38-4	6979-6981	no	_
38-5	6982-6989	optimal	_
38-6	6990-6993	way	_
38-7	6994-6996	to	_
38-8	6997-7003	select	_
38-9	7004-7005	T	_
38-10	7006-7007	,	_
38-11	7008-7012	here	_
38-12	7013-7016	the	_
38-13	7017-7022	range	_
38-14	7023-7025	of	_
38-15	7026-7030	0.15	_
38-16	7031-7032	<	_
38-17	7033-7034	T	_
38-18	7035-7036	<	_
38-19	7037-7041	0.45	_
38-20	7042-7043	(	_
38-21	7044-7046	in	_
38-22	7047-7051	step	_
38-23	7052-7054	of	_
38-24	7055-7060	0.005	_
38-25	7061-7062	)	_
38-26	7063-7066	was	_
38-27	7067-7075	selected	_
38-28	7076-7079	for	_
38-29	7080-7083	the	_
38-30	7084-7088	four	_
38-31	7089-7094	bands	_
38-32	7095-7096	.	_

39-1	7097-7099	It	_
39-2	7100-7102	is	_
39-3	7103-7113	well-known	_
39-4	7114-7118	that	_
39-5	7119-7122	the	_
39-6	7123-7127	edge	_
39-7	7128-7134	number	_
39-8	7135-7137	in	_
39-9	7138-7139	a	_
39-10	7140-7145	graph	_
39-11	7146-7149	has	_
39-12	7150-7151	a	_
39-13	7152-7157	great	_
39-14	7158-7170	relationship	_
39-15	7171-7175	with	_
39-16	7176-7179	the	_
39-17	7180-7186	values	_
39-18	7187-7189	of	_
39-19	7190-7191	L	_
39-20	7192-7195	and	_
39-21	7196-7197	C	_
39-22	7198-7199	,	_
39-23	7200-7203	and	_
39-24	7204-7207	the	_
39-25	7208-7212	edge	_
39-26	7213-7219	number	_
39-27	7220-7222	in	_
39-28	7223-7226	the	_
39-29	7227-7228	2	_
39-30	7229-7235	graphs	_
39-31	7236-7237	(	_
39-32	7238-7240	SZ	_
39-33	7241-7249	patients	_
39-34	7250-7253	and	_
39-35	7254-7261	healthy	_
39-36	7262-7270	controls	_
39-37	7271-7272	)	_
39-38	7273-7277	will	_
39-39	7278-7280	be	_
39-40	7281-7290	different	_
39-41	7291-7293	by	_
39-42	7294-7302	applying	_
39-43	7303-7304	a	_
39-44	7305-7312	certain	_
39-45	7313-7315	T.	_
39-46	7316-7325	Therefore	_
39-47	7326-7327	,	_
39-48	7328-7330	in	_
39-49	7331-7336	order	_
39-50	7337-7339	to	_
39-51	7340-7349	eliminate	_
39-52	7350-7354	this	_
39-53	7355-7361	effect	_
39-54	7362-7363	,	_
39-55	7364-7367	the	_
39-56	7368-7369	L	_
39-57	7370-7373	and	_
39-58	7374-7375	C	_
39-59	7376-7380	were	_
39-60	7381-7391	calculated	_
39-61	7392-7394	as	_
39-62	7395-7396	a	_
39-63	7397-7405	function	_
39-64	7406-7408	of	_
39-65	7409-7415	degree	_
39-66	7416-7417	K	_
39-67	7418-7419	(	_
39-68	7420-7421	2	_
39-69	7422-7423	<	_
39-70	7424-7425	K	_
39-71	7426-7427	<	_
39-72	7428-7429	8	_
39-73	7430-7431	,	_
39-74	7432-7434	in	_
39-75	7435-7439	step	_
39-76	7440-7442	of	_
39-77	7443-7446	0.1	_
39-78	7447-7448	)	_
39-79	7449-7450	.	_

40-1	7451-7459	Recently	_
40-2	7460-7461	,	_
40-3	7462-7473	Dimitriadis	_
40-4	7474-7476	et	_
40-5	7477-7479	al	_
40-6	7480-7481	.	_

41-1	7482-7490	proposed	_
41-2	7491-7492	a	_
41-3	7493-7498	novel	_
41-4	7499-7510	data-driven	_
41-5	7511-7522	topological	_
41-6	7523-7532	filtering	_
41-7	7533-7539	scheme	_
41-8	7540-7545	based	_
41-9	7546-7548	on	_
41-10	7549-7553	OMST	_
41-11	7554-7555	,	_
41-12	7556-7561	which	_
41-13	7562-7569	filters	_
41-14	7570-7575	brain	_
41-15	7576-7588	connectivity	_
41-16	7589-7597	networks	_
41-17	7598-7603	based	_
41-18	7604-7606	on	_
41-19	7607-7610	the	_
41-20	7611-7623	optimization	_
41-21	7624-7631	between	_
41-22	7632-7635	the	_
41-23	7636-7642	global	_
41-24	7643-7653	efficiency	_
41-25	7654-7656	of	_
41-26	7657-7660	the	_
41-27	7661-7668	network	_
41-28	7669-7672	and	_
41-29	7673-7676	the	_
41-30	7677-7681	cost	_
41-31	7682-7692	preserving	_
41-32	7693-7696	its	_
41-33	7697-7703	wiring	_
41-34	7704-7705	.	_

42-1	7706-7710	Here	_
42-2	7711-7712	,	_
42-3	7713-7715	we	_
42-4	7716-7721	tried	_
42-5	7722-7727	using	_
42-6	7728-7731	the	_
42-7	7732-7736	OMST	_
42-8	7737-7743	method	_
42-9	7744-7746	to	_
42-10	7747-7753	filter	_
42-11	7754-7757	the	_
42-12	7758-7769	constructed	_
42-13	7770-7775	brain	_
42-14	7776-7784	networks	_
42-15	7785-7788	and	_
42-16	7789-7799	recomputed	_
42-17	7800-7805	graph	_
42-18	7806-7817	theoretical	_
42-19	7818-7826	measures	_
42-20	7827-7828	.	_

43-1	7829-7834	After	_
43-2	7835-7838	the	_
43-3	7839-7841	MI	_
43-4	7842-7848	matrix	_
43-5	7849-7852	was	_
43-6	7853-7862	converted	_
43-7	7863-7867	into	_
43-8	7868-7870	an	_
43-9	7871-7881	undirected	_
43-10	7882-7888	binary	_
43-11	7889-7894	graph	_
43-12	7895-7896	,	_
43-13	7897-7900	the	_
43-14	7901-7906	graph	_
43-15	7907-7918	theoretical	_
43-16	7919-7927	measures	_
43-17	7928-7929	,	_
43-18	7930-7934	such	_
43-19	7935-7937	as	_
43-20	7938-7952	characteristic	_
43-21	7953-7957	path	_
43-22	7958-7964	length	_
43-23	7965-7966	L	_
43-24	7967-7970	and	_
43-25	7971-7978	cluster	_
43-26	7979-7990	coefficient	_
43-27	7991-7992	C	_
43-28	7993-7994	,	_
43-29	7995-7999	were	_
43-30	8000-8008	computed	_
43-31	8009-8010	.	_

44-1	8011-8019	Detailed	_
44-2	8020-8032	descriptions	_
44-3	8033-8036	and	_
44-4	8037-8048	calculation	_
44-5	8049-8056	methods	_
44-6	8057-8060	for	_
44-7	8061-8062	L	_
44-8	8063-8066	and	_
44-9	8067-8068	C	_
44-10	8069-8074	could	_
44-11	8075-8077	be	_
44-12	8078-8083	found	_
44-13	8084-8086	in	_
44-14	8087-8091	some	_
44-15	8092-8102	previously	_
44-16	8103-8112	published	_
44-17	8113-8123	literature	_
44-18	8124-8125	.	_

45-1	8126-8129	The	_
45-2	8130-8141	small-world	_
45-3	8142-8149	network	_
45-4	8150-8152	is	_
45-5	8153-8166	characterized	_
45-6	8167-8169	by	_
45-7	8170-8171	a	_
45-8	8172-8179	similar	_
45-9	8180-8184	path	_
45-10	8185-8191	length	_
45-11	8192-8195	and	_
45-12	8196-8202	higher	_
45-13	8203-8210	cluster	_
45-14	8211-8222	coefficient	_
45-15	8223-8231	compared	_
45-16	8232-8234	to	_
45-17	8235-8236	a	_
45-18	8237-8243	random	_
45-19	8244-8251	network	_
45-20	8252-8253	,	_
45-21	8254-8258	that	_
45-22	8259-8261	is	_
45-23	8262-8263	,	_
45-24	8264-8265	γ	_
45-25	8266-8267	=	_
45-26	8268-8281	Creal/Crandom	_
45-27	8282-8283	>	_
45-28	8284-8285	1	_
45-29	8286-8287	,	_
45-30	8288-8289	λ	_
45-31	8290-8291	=	_
45-32	8292-8305	Lreal/Lrandom	_
45-33	8306-8307	≈	_
45-34	8308-8309	1	_
45-35	8310-8311	.	_

46-1	8312-8315	And	_
46-2	8316-8319	the	_
46-3	8320-8331	small-world	_
46-4	8332-8337	index	_
46-5	8338-8343	could	_
46-6	8344-8346	be	_
46-7	8347-8354	defined	_
46-8	8355-8357	as	_
46-9	8358-8359	σ	_
46-10	8360-8361	=	_
46-11	8362-8365	γ/λ	_
46-12	8366-8367	.	_

47-1	8368-8371	For	_
47-2	8372-8375	the	_
47-3	8376-8387	small-world	_
47-4	8388-8395	network	_
47-5	8396-8397	,	_
47-6	8398-8401	the	_
47-7	8402-8403	σ	_
47-8	8404-8406	is	_
47-9	8407-8414	greater	_
47-10	8415-8419	than	_
47-11	8420-8421	1	_
47-12	8422-8423	.	_

48-1	8424-8428	Here	_
48-2	8429-8430	,	_
48-3	8431-8433	in	_
48-4	8434-8439	order	_
48-5	8440-8442	to	_
48-6	8443-8450	compute	_
48-7	8451-8462	small-world	_
48-8	8463-8470	indexes	_
48-9	8471-8473	of	_
48-10	8474-8486	experimental	_
48-11	8487-8495	networks	_
48-12	8496-8497	(	_
48-13	8498-8500	SZ	_
48-14	8501-8509	patients	_
48-15	8510-8513	and	_
48-16	8514-8521	healthy	_
48-17	8522-8530	controls	_
48-18	8531-8532	)	_
48-19	8533-8534	,	_
48-20	8535-8540	after	_
48-21	8541-8549	applying	_
48-22	8550-8553	the	_
48-23	8554-8558	OMST	_
48-24	8559-8568	filtering	_
48-25	8569-8575	scheme	_
48-26	8576-8577	,	_
48-27	8578-8581	300	_
48-28	8582-8588	random	_
48-29	8589-8597	networks	_
48-30	8598-8602	were	_
48-31	8603-8612	generated	_
48-32	8613-8616	for	_
48-33	8617-8621	each	_
48-34	8622-8634	experimental	_
48-35	8635-8642	network	_
48-36	8643-8645	by	_
48-37	8646-8651	using	_
48-38	8652-8655	the	_
48-39	8656-8668	Markov-chain	_
48-40	8669-8678	algorithm	_
48-41	8679-8680	.	_

49-1	8681-8683	As	_
49-2	8684-8685	a	_
49-3	8686-8692	result	_
49-4	8693-8694	,	_
49-5	8695-8698	the	_
49-6	8699-8703	mean	_
49-7	8704-8715	small-world	_
49-8	8716-8721	index	_
49-9	8722-8723	σ	_
49-10	8724-8726	of	_
49-11	8727-8739	experimental	_
49-12	8740-8748	networks	_
49-13	8749-8750	(	_
49-14	8751-8753	SZ	_
49-15	8754-8762	patients	_
49-16	8763-8766	and	_
49-17	8767-8774	healthy	_
49-18	8775-8783	controls	_
49-19	8784-8785	)	_
49-20	8786-8789	was	_
49-21	8790-8798	computed	_
49-22	8799-8800	.	_

50-1	8801-8804	2.4	_
50-2	8805-8806	.	_

51-1	8807-8818	Statistical	_
51-2	8819-8827	Analysis	_
51-3	8828-8831	All	_
51-4	8832-8843	statistical	_
51-5	8844-8852	analyses	_
51-6	8853-8857	were	_
51-7	8858-8865	carried	_
51-8	8866-8869	out	_
51-9	8870-8875	using	_
51-10	8876-8880	SPSS	_
51-11	8881-8888	version	_
51-12	8889-8893	21.0	_
51-13	8894-8902	software	_
51-14	8903-8904	(	_
51-15	8905-8909	SPSS	_
51-16	8910-8914	Inc.	_
51-17	8915-8916	,	_
51-18	8917-8924	Chicago	_
51-19	8925-8926	,	_
51-20	8927-8929	IL	_
51-21	8930-8931	)	_
51-22	8932-8933	.	_

52-1	8934-8937	The	_
52-2	8938-8950	Shapiro-Wilk	_
52-3	8951-8955	test	_
52-4	8956-8959	was	_
52-5	8960-8964	used	_
52-6	8965-8967	to	_
52-7	8968-8972	test	_
52-8	8973-8976	for	_
52-9	8977-8986	normality	_
52-10	8987-8989	of	_
52-11	8990-9002	distribution	_
52-12	9003-9004	.	_

53-1	9005-9009	Task	_
53-2	9010-9021	performance	_
53-3	9022-9023	,	_
53-4	9024-9028	such	_
53-5	9029-9031	as	_
53-6	9032-9041	execution	_
53-7	9042-9046	time	_
53-8	9047-9050	and	_
53-9	9051-9056	error	_
53-10	9057-9063	number	_
53-11	9064-9065	,	_
53-12	9066-9069	was	_
53-13	9070-9083	statistically	_
53-14	9084-9092	compared	_
53-15	9093-9100	between	_
53-16	9101-9103	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Thing
53-17	9104-9112	patients	_
53-18	9113-9116	and	_
53-19	9117-9124	healthy	_
53-20	9125-9133	controls	_
53-21	9134-9136	by	_
53-22	9137-9142	using	_
53-23	9143-9154	independent	_
53-24	9155-9161	sample	_
53-25	9162-9168	t-test	_
53-26	9169-9170	.	_

54-1	9171-9174	The	_
54-2	9175-9186	differences	_
54-3	9187-9189	of	_
54-4	9190-9191	C	_
54-5	9192-9195	and	_
54-6	9196-9197	L	_
54-7	9198-9205	between	_
54-8	9206-9208	SZ	_
54-9	9209-9217	patients	_
54-10	9218-9221	and	_
54-11	9222-9229	healthy	_
54-12	9230-9238	controls	_
54-13	9239-9242	for	_
54-14	9243-9247	each	_
54-15	9248-9253	value	_
54-16	9254-9258	over	_
54-17	9259-9260	a	_
54-18	9261-9266	range	_
54-19	9267-9269	of	_
54-20	9270-9271	T	_
54-21	9272-9274	or	_
54-22	9275-9281	degree	_
54-23	9282-9283	K	_
54-24	9284-9288	were	_
54-25	9289-9297	compared	_
54-26	9298-9300	by	_
54-27	9301-9306	using	_
54-28	9307-9310	the	_
54-29	9311-9323	Mann–Whitney	_
54-30	9324-9325	U	_
54-31	9326-9330	test	_
54-32	9331-9332	.	_

55-1	9333-9335	In	_
55-2	9336-9344	addition	_
55-3	9345-9346	,	_
55-4	9347-9354	Pearson	_
55-5	9355-9366	correlation	_
55-6	9367-9375	analysis	_
55-7	9376-9379	was	_
55-8	9380-9387	applied	_
55-9	9388-9390	to	_
55-10	9391-9398	explore	_
55-11	9399-9406	whether	_
55-12	9407-9412	there	_
55-13	9413-9420	existed	_
55-14	9421-9432	correlation	_
55-15	9433-9440	between	_
55-16	9441-9442	C	_
55-17	9443-9445	or	_
55-18	9446-9447	L	_
55-19	9448-9451	and	_
55-20	9452-9456	task	_
55-21	9457-9468	performance	_
55-22	9469-9470	.	_

56-1	9471-9472	P	_
56-2	9473-9474	<	_
56-3	9475-9479	0.05	_
56-4	9480-9486	showed	_
56-5	9487-9491	that	_
56-6	9492-9493	a	_
56-7	9494-9505	significant	_
56-8	9506-9516	difference	_
56-9	9517-9524	existed	_
56-10	9525-9526	.	_

